Cerulean Pharma reported $0 in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adamis Pharmaceuticals ADMP:US 1.85M 1.85M
Agile Therapeutics AGRX:US $ 12.25M 4.58M
Arrowhead Research ARWR:US $ 0M 0M
Bayer BAYN:GR € 42547M 1675M
Biocept BIOC:US $ 2.24M 0.27M
Brainstorm Cell Therapeutics BCLI:US $ 0M 0M
Cerulean Pharma CERU:US $ 0M 0M
Immunogen IMGN:US $ 0M 0M
Johnson & Johnson JNJ:US $ 33148M 603M
Macrogenics MGNX:US $ 0M 0M
Merk MRK:US $ 31794M 1308M
Nektar Therapeutics NKTR:US $ 0M 0M
Perrigo Ordinary Shares PRGO:US $ 3515.2M 5.3M
Pfizer PFE:US $ 36301M 2135M
Seattle Genetics SGEN:US $ 0M 0M
YTE INCY:US $ 34.18M 0.09M